AAV Gene Therapy for MPS1-associated Corneal Blindness

Although cord blood transplantation has significantly extended the lifespan of mucopolysaccharidosis type 1 (MPS1) patients, over 95% manifest cornea clouding with about 50% progressing to blindness. As corneal transplants are met with high rejection rates in MPS1 children, there remains no treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Vance, Melisa, Llanga, Telmo, Bennett, Will, Woodard, Kenton, Murlidharan, Giridhar, Chungfat, Neil, Asokan, Aravind, Gilger, Brian, Kurtzberg, Joanne, Samulski, R. Jude, Hirsch, Matthew L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761992/
https://www.ncbi.nlm.nih.gov/pubmed/26899286
http://dx.doi.org/10.1038/srep22131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761992/
https://www.ncbi.nlm.nih.gov/pubmed/26899286
http://dx.doi.org/10.1038/srep22131

Ejemplares similares